Results 1 to 10 of about 1,740 (124)

Nicotine receptor partial agonists for smoking cessation [PDF]

open access: yesSao Paulo Medical Journal, 2007
Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract withdrawal symptoms (acting as an agonist) and reducing smoking satisfaction (acting as an antagonist). Varenicline was developed as a nicotine receptor partial agonist from cytisine, a drug widely used in central
Cahill, Kate   +3 more
openaire   +10 more sources

Nicotine receptor partial agonists for smoking cessation

open access: yesCochrane Database of Systematic Reviews, 2023
Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract withdrawal symptoms (acting as an agonist) and reducing smoking satisfaction (acting as an antagonist). This is an update of a Cochrane Review first published in 2007.To assess the effectiveness of nicotine ...
Livingstone-Banks, J   +6 more
openaire   +4 more sources

TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors [PDF]

open access: yesFrontiers in Pharmacology, 2017
(E)-5-(Pyrimidin-5-yl)-1,2,3,4,7,8-hexahydroazocine (TC299423) is a novel agonist for nicotinic acetylcholine receptors (nAChRs).
Teagan R. Wall   +12 more
openaire   +6 more sources

Nicotine receptor partial agonists for smoking cessation [PDF]

open access: yesCochrane Database of Systematic Reviews, 2016
Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract withdrawal symptoms (acting as an agonist) and reducing smoking satisfaction (acting as an antagonist).To review the efficacy of nicotine receptor partial agonists, including varenicline and cytisine, for smoking ...
Cahill, Kate   +4 more
openaire   +5 more sources

Dynamic imaging and characterization of volatile aerosols in e-cigarette emissions using deep learning-based holographic microscopy [PDF]

open access: yesACS Sensors (2021), 2021
Various volatile aerosols have been associated with adverse health effects; however, characterization of these aerosols is challenging due to their dynamic nature. Here we present a method that directly measures the volatility of particulate matter (PM) using computational microscopy and deep learning.
arxiv   +1 more source

Alpha7 nicotinic acetylcholine receptor signaling modulates ovine fetal brain astrocytes transcriptome in response to endotoxin [PDF]

open access: yesFront. Immunol. 2019, 2018
Neuroinflammation in utero may result in lifelong neurological disabilities. Astrocytes play a pivotal role, but the mechanisms are poorly understood. No early postnatal treatment strategies exist to enhance neuroprotective potential of astrocytes. We hypothesized that agonism on alpha7 nicotinic acetylcholine receptor (alpha7nAChR) in fetal astrocytes
arxiv   +1 more source

Molecular adsorption study of nicotine and caffeine on the single-walled carbon nanotube from first principles [PDF]

open access: yesSolid State Communications, v.167, pp.27 - 30 (2013), 2012
Using first-principles calculations, we investigate the electronic structures and binding properties of nicotine and caffeine adsorbed on single-walled carbon nanotubes to determine whether CNTs are appropriate for filtering or sensing nicotine and caffeine molecules. We find that caffeine adsorbs more strongly than nicotine.
arxiv   +1 more source

Activation of muscle nicotinic acetylcholine receptor channels by nicotinic and muscarinic agonists [PDF]

open access: yesBritish Journal of Pharmacology, 1999
The dose‐response parameters of recombinant mouse adult neuromuscular acetylcholine receptor channels (nAChR) activated by carbamylcholine, nicotine, muscarine and oxotremorine were measured. Rate constants for agonist association and dissociation, and channel opening and closing, were estimated from single‐channel kinetic analysis.
Gustav Akk, Anthony Auerbach
openaire   +3 more sources

Silent agonists for α7 nicotinic acetylcholine receptors

open access: yesPharmacological Research, 2023
We discuss models for the activation and desensitization of α7 nicotinic acetylcholine receptors (nAChRs) and the effects of efficacious type II positive allosteric modulators (PAMs) that destabilize α7 desensitized states. Type II PAMs such as PNU-120596 can be used to distinguish inactive compounds from silent agonists, compounds that produce little ...
Roger L. Papke   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy